Coya Therapeutics, Inc.
COYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $96,169 | $108,185 | $93,726 |
| - Cash | $28,130 | $29,757,328 | $35,531 | $38,340 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | -$29,661,159 | $72,654 | $55,386 |
| Revenue | $3,564 | $164 | $258 | $2 |
| % Growth | 2,078.4% | -36.6% | 13,111.3% | – |
| Gross Profit | $3,557 | $157 | -$4,956 | -$1,935 |
| % Margin | 99.8% | 95.8% | -1,921.9% | -99,154.1% |
| EBITDA | -$2,109 | -$6,088 | -$7,670 | -$4,073 |
| % Margin | -59.2% | -3,721% | -2,974.2% | -208,681.1% |
| Net Income | -$2,116 | -$6,095 | -$7,307 | -$2,916 |
| % Margin | -59.4% | -3,725.2% | -2,833.4% | -149,373.8% |
| EPS Diluted | -0.13 | -0.36 | -0.44 | -0.18 |
| % Growth | 63.9% | 18.2% | -144.4% | – |
| Operating Cash Flow | -$1,131 | -$5,773 | -$2,828,275 | -$2,410 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$1,131 | -$5,773 | -$2,828,275 | -$2,410 |